Physician profile
Mykola John Bartkiw
NPI 1861619736
$8,999.60
in general payments reported to CMS, 2019-2025
35 companies · $469 in 2025
The $469 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $308 · 2021: $938 · 2022: $115 · 2023: $1,277 · 2024: $5,479 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,650 · Food and Beverage: $2,335 · Travel and Lodging: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,650.00 |
| Food and Beverage | $2,334.91 |
| Travel and Lodging | $239.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,889.56 | 2023-2024 | |
| Acumed LLC | $767.32 | 2019-2023 | Innate Implant, Inframe Implant |
| Depuy Synthes Sales INC. | $318.74 | 2023-2025 | Va-Lcp, Na |
| Pinnacle, INC | $299.42 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $281.35 | 2019-2025 | Euflexxa |
| Globus Medical, INC. | $238.92 | 2024 | Clavicular Fracture Fixation, Distal Radius II |
| Encore Medical, LP | $224.82 | 2023 | Djo Surgical |
| Horizon Therapeutics Plc | $202.32 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $196.49 | 2024 | Tapestry |
| Axogen | $161.12 | 2025 | |
| Pacira Therapeutics, INC. | $122.46 | 2019-2021 | |
| Smith+Nephew, INC. | $117.44 | 2023-2024 | Healicoil, Pico 7 |
| Bioventus LLC | $115.59 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $111.05 | 2024-2025 | Exparel, Iovera, Zilretta |
| Stryker Corporation | $99.56 | 2019-2024 | Conextions Tr Tendon Repair System-Implant Mechanism, Stryker |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $84.70 | 2023 | Integra, Tenoglide, Primatrix |
| Trimed, INC. | $77.05 | 2020 | |
| Osteomed LLC | $75.00 | 2019 | |
| Medtronic, INC. | $67.74 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Skeletal Dynamics INC | $61.80 | 2023 | Ijs, Geminus, Align |
| Bsn Medical INC | $59.27 | 2022 | |
| Orthofix Medical, INC. | $57.84 | 2021-2024 | Cervical-Stim, Physio-Stim |
| Amgen INC. | $46.04 | 2024-2025 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $38.60 | 2024-2025 | |
| Djo, LLC | $37.26 | 2023-2025 | Cmf |
| Convatec INC. | $35.17 | 2021-2022 | |
| Dynasplint Systems INC. | $32.01 | 2023 | Dynasplint |
| Orthogenrx INC. | $31.72 | 2019 | |
| Fidia Pharma USA INC. | $31.08 | 2024 | Hymovis, Triluron |
| Spineology INC. | $27.88 | 2022 | |
| Organogenesis INC. | $22.44 | 2025 | Puraply Wound Matrix |
| Mimedx Group, INC. | $20.67 | 2024 | |
| Sonex Health, INC. | $19.31 | 2024 | Sx-One Microknife |
| Pfizer INC. | $16.19 | 2020 | |
| Anika Therapeutics, INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mykola Bartkiw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.